TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
-14.07%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.34B
AUM Growth
+$2.34B
(-15%)
Cap. Flow
+$15.8M
Cap. Flow
% of AUM
0.67%
Top 10 Holdings %
Top 10 Hldgs %
40.93%
Holding
221
New
9
Increased
52
Reduced
52
Closed
18
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$14.9M |
| 2 |
Medtronic
MDT
|
$12.9M |
| 3 |
UnitedHealth
UNH
|
$7.69M |
| 4 |
Pfizer
PFE
|
$7.1M |
| 5 |
Merck
MRK
|
$7.1M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$17M |
| 2 |
AstraZeneca
AZN
|
$11M |
| 3 |
Idexx Laboratories
IDXX
|
$9.46M |
| 4 |
Omega Healthcare
OHI
|
$7.02M |
| 5 |
Viatris
VTRS
|
$6.94M |
Sector Composition
| 1 | Healthcare | 94.39% |
| 2 | Real Estate | 2.48% |
| 3 | Financials | 0% |
